COO vs. DXCM: Cooper vs. DexCom Stock Comparison
How do Cooper (COO) and DexCom (DXCM) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Cooper (COO) and DexCom (DXCM) both belong to the Health Care Equipment & Supplies industry, though COO is classified under Health Care Supplies while DXCM falls under Health Care Equipment.
| Profile Item | COO | DXCM |
|---|---|---|
| Name | The Cooper Companies, Inc. | DexCom Inc. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Supplies | Health Care Equipment |
| Market Capitalization | 11.86 billion USD | 29.62 billion USD |
| Currency | USD | USD |
| Exchange | Nasdaq | Nasdaq |
| Listing Date | January 21, 1983 | April 14, 2005 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | COO | DXCM |
|---|---|---|
| Total Return (1Y) | -9.72% | 46.33% |
| Total Return (3Y, Annualized) | -8.06% | -4.50% |
| Total Return (5Y, Annualized) | -10.20% | -12.76% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | COO | DXCM |
|---|---|---|
| Volatility (1Y, Annualized) | 32.67% | 38.37% |
| Beta (5Y) | 0.79 | 1.43 |
| Max Drawdown (5Y) | -52.11% | -66.32% |
| Avg. Volume (3M) | 3.47M | 4.34M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | COO | DXCM |
|---|---|---|
| Sharpe Ratio (1Y) | -0.43 | 1.10 |
| Sortino Ratio (1Y) | -0.59 | 1.79 |
Profitability
ROE (TTM)
DexCom (DXCM) at 37.67% sits in the top ROE quartile, while Cooper (COO) at 6.84% is closer to the peer norm — stronger capital efficiency for DXCM.
COO
Health Care Equipment & Services industry group
6.84%
- Max
- 47.61%
- Q3
- 14.36%
- COO
- 6.84%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
DXCM
Health Care Equipment & Services industry group
37.67%
- Max
- 47.61%
- DXCM
- 37.67%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
For every dollar of sales, both Cooper (COO) at 13.46% and DexCom (DXCM) at 19.42% retain more as net profit than most peers, landing in the top net margin quartile of their industries.
COO
Health Care Equipment & Services industry group
13.46%
- Max
- 29.35%
- COO
- 13.46%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
DXCM
Health Care Equipment & Services industry group
19.42%
- Max
- 29.35%
- DXCM
- 19.42%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Both Cooper (COO) at 20.82% and DexCom (DXCM) at 24.34% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.
COO
Health Care Equipment & Services industry group
20.82%
- Max
- 35.43%
- COO
- 20.82%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
DXCM
Health Care Equipment & Services industry group
24.34%
- Max
- 35.43%
- DXCM
- 24.34%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | COO | DXCM |
|---|---|---|
| ROE (TTM) | 6.84% | 37.67% |
| ROA (TTM) | 2.74% | 11.14% |
| Net Margin (TTM) | 13.46% | 19.42% |
| Operating Margin (TTM) | 20.82% | 24.34% |
| Gross Margin (TTM) | 65.93% | 63.42% |
Growth
Revenue Growth
Both Cooper (COO) at 5.06% and DexCom (DXCM) at 15.60% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
DexCom (DXCM) at 47.18% sits in the top EPS growth quartile, while Cooper (COO) at -4.59% is closer to the peer norm — faster per-share earnings growth for DXCM.
Growth Metrics
| Metric | COO | DXCM |
|---|---|---|
| Revenue Growth (YoY) | 5.06% | 15.60% |
| Revenue Growth (3Y CAGR) | 7.35% | 17.01% |
| EPS Growth (YoY) | -4.59% | 47.18% |
| EPS Growth (3Y CAGR) | -1.22% | 36.60% |
Financial Strength
Current Ratio (MRQ)
DexCom (DXCM) at 1.74 keeps current ratio within its industry’s typical mid-range, while Cooper (COO) at 1.22 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for COO.
COO
Health Care Equipment & Services industry group
1.22
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- COO
- 1.22
- Min
- 0.30
DXCM
Health Care Equipment & Services industry group
1.74
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- DXCM
- 1.74
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Both Cooper (COO) at 0.34 and DexCom (DXCM) at 0.55 fund their balance sheets with roughly industry-typical debt-to-equity mixes.
COO
Health Care Equipment & Services industry group
0.34
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- COO
- 0.34
- Q1
- 0.16
- Min
- 0.00
DXCM
Health Care Equipment & Services industry group
0.55
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- DXCM
- 0.55
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | COO | DXCM |
|---|---|---|
| Current Ratio (MRQ) | 1.22 | 1.74 |
| Debt / Equity (MRQ) | 0.34 | 0.55 |
| Net Debt / EBITDA | 2.84 | -0.28 |
Dividends
Dividend Yield (TTM)
Neither Cooper (COO) nor DexCom (DXCM) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
COO
Health Care Equipment & Services industry group
0.00%
- COO
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
DXCM
Health Care Equipment & Services industry group
0.00%
- DXCM
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Neither Cooper (COO) nor DexCom (DXCM) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
COO
Health Care Equipment & Services industry group
0.00%
- COO
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
DXCM
Health Care Equipment & Services industry group
0.00%
- DXCM
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | COO | DXCM |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
P/E Ratio (TTM)
Both Cooper (COO) at 21.43 and DexCom (DXCM) at 31.26 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.
COO
Health Care Equipment & Services industry group
21.43
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- COO
- 21.43
- Q1
- 21.19
- Min
- 4.21
DXCM
Health Care Equipment & Services industry group
31.26
- Max
- 80.41
- Q3
- 47.62
- DXCM
- 31.26
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
Cooper (COO) at 2.80 is priced about in line with its industry on P/S ratio, while DexCom (DXCM) at 5.80 sits in the pricier quartile — DXCM costs more per dollar of sales.
COO
Health Care Equipment & Services industry group
2.80
- Max
- 8.80
- Q3
- 4.32
- COO
- 2.80
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
DXCM
Health Care Equipment & Services industry group
5.80
- Max
- 8.80
- DXCM
- 5.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
Cooper (COO) at 1.42 looks cheap against book in the lower P/B ratio quartile, while DexCom (DXCM) at 11.68 carries a premium in the upper quartile — a clear price-to-book gap.
COO
Health Care Equipment & Services industry group
1.42
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- COO
- 1.42
- Min
- -1.31
DXCM
Health Care Equipment & Services industry group
11.68
- DXCM
- 11.68
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | COO | DXCM |
|---|---|---|
| P/E Ratio (TTM) | 21.43 | 31.26 |
| P/S Ratio (TTM) | 2.80 | 5.80 |
| P/B Ratio (MRQ) | 1.42 | 11.68 |
| Free Cash Flow Yield (TTM) | 4.58% | 2.74% |